POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial
Jane F. ApperleyMemorial Sloan Kettering Cancer Center, New York, USAJörge E. CortesKlinikum der Goethe-Universität, Frankfurt, GermanyElias JabbourLLC Hema, Moscow, Russian FederationAndreas HochhausGuy's and St Thomas' NHS Foundation Trust, London, United KingdomTimothy P. HughesRussian Research Institute of Hematology and Transfusiology, St. Petersburg, UzbekistanCharles ChuahEnliven Therapeutics, Boulder, USAHugues de LavalladeDar El-Salam Cancer Center, Cairo, EgyptMichael W. DeiningerUniversitätsklinikum Jena, Jena, GermanyJeffrey H. LiptonPrincess Margaret Cancer Centre, Toronto, CanadaElza LomaiaRepublican Specialized Hematological Scientific and Practical Medical Center, Tashkent, Uzbekistan, Tashkent, UzbekistanLori J. ManessUniversity of Nebraska Medical Center, Omaha, USAMichael J. MauroAlmazov National Medical Research Centre, St. Petersburg, Russian FederationJames A. McCloskeyJohn Theurer Cancer Center at Hackensack Meridian Health, Hackensack, USABeatriz MoiraghiHospital Jose Maria Ramos Mejía, Buenos Aires, ArgentinaCarolina PavlovskyFundaleu, Buenos Aires, ArgentinaChristine RojasCentro de Investigaciones Clinicas Vina del Mar, Valparaíso, ChilePhilippe RousselotCentre Hospitalier de Versailles Université de Versailles Saint-Quentin-en-Yvelines, Paris, FranceTomasz SachaJagiellonian University Hospital in Krakow, Krakow, PolandMoshe TalpazMichigan Center for Translational PathologyAnna TurkinaNational Medical Research Center for Hematology, Moscow, Russian FederationMaria Undurraga SuttonHospital del Salvador, Santiago, ChileXiaowei RenTakeda Development Center Americas, Inc., Lexington, USAAlexander VorogTakeda Development Center Americas, Inc., Lexington, USAGianantonio RostiIstituti di Ricovero e Cura a Carattere Scientifico
ABI
Annotatsiya
Annotatsiya mavjud emas.
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba